Latest 23andMe Inc. Stories
Privacy and Health Information Technology Expert Joins 23andMe Leadership Team MOUNTAIN VIEW, Calif., Feb.
BRONX, N.Y., Feb.
23andMe's Personal Genome Service® 510(k) Submission for Bloom Syndrome Carrier Status Test Report Granted Marketing Authority through De Novo Classification MOUNTAIN VIEW, Calif.,
First ever genome-wide association study on motion sickness links 35 genetic variants to the condition; some variants display stronger effects in women MOUNTAIN VIEW, Calif., Feb.
Agreement Provides Pfizer with Access to 23andMe's Research Portal; Companies to Establish New Lupus Research Community in 2015 MOUNTAIN VIEW, Calif., Jan.
Collaboration Aims to Generate New Therapeutic Approaches for Chronic Diseases SAN FRANCISCO, Jan.
New program will support the identification of novel drug targets to treat Parkinson's disease MOUNTAIN VIEW, Calif., Jan.
First large-scale nationwide analysis yields maps of genetic ancestry that reflect US history MOUNTAIN VIEW, Calif., Dec.
23andMe Leadership Team Adds Veteran Genomics Marketing Professional MOUNTAIN VIEW, Calif., Oct.
Leading personal genetics company now offers both health and ancestry information exclusively to Canadians as part of 23andMe's Personal Genome Service(®) MOUNTAIN VIEW, CA,
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.